marimastat has been researched along with Carcinoma, Small Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezjak, A; Debruyne, C; Giaccone, G; Hirsh, V; Krzakowski, M; Lamont, A; Martins, H; Rubin, S; Sadura, A; Seymour, L; Shepherd, FA; Smylie, M; Zee, B | 1 |
| Bout, JC; Soncin, F; Vandenbunder, B | 1 |
| Fukuoka, M | 1 |
1 review(s) available for marimastat and Carcinoma, Small Cell
| Article | Year |
|---|---|
[Progress in diagnosis and treatment of lung cancer].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Endothelial Growth Factors; Enzyme Inhibitors; Gefitinib; Genetic Therapy; Humans; Hydroxamic Acids; Lung Neoplasms; Lymphokines; Mass Screening; Metalloendopeptidases; Quinazolines; Receptor Protein-Tyrosine Kinases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
1 trial(s) available for marimastat and Carcinoma, Small Cell
| Article | Year |
|---|---|
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Orga
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Canada; Carcinoma, Small Cell; Double-Blind Method; Enzyme Inhibitors; Europe; Female; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Metalloendopeptidases; Middle Aged; Patient Compliance; Proportional Hazards Models; Prospective Studies; Quality of Life; Survival Analysis; Treatment Outcome | 2002 |
1 other study(ies) available for marimastat and Carcinoma, Small Cell
| Article | Year |
|---|---|
[Therapeutic prospects of angiogenesis inhibitors in cancerology].
Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Collagen; Endostatins; Humans; Hydroxamic Acids; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Mice; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Peptide Fragments; Plasminogen; Protease Inhibitors; Randomized Controlled Trials as Topic | 1999 |